PUBLISHER: Grand View Research | PRODUCT CODE: 1888735
PUBLISHER: Grand View Research | PRODUCT CODE: 1888735
The global peripheral vascular imaging contrast media market size was estimated at USD 499.77 million in 2024 and is projected to reach USD 768.82 million by 2033, growing at a CAGR of 4.95% from 2025 to 2033. The market growth is attributed to the rising global prevalence of cardiovascular diseases (CVDs), peripheral artery disease (PAD), and diabetes-related vascular complications, which are increasing the demand for accurate diagnostic imaging.
The growing adoption of minimally invasive diagnostic procedures, such as CT angiography, MR angiography, and digital subtraction angiography, enhances the need for advanced contrast agents providing high vascular visibility and improved safety profiles. Technological advancements, including low-osmolar and iso-osmolar iodinated contrast media, as well as gadolinium-based agents with reduced nephrotoxicity risks, enhance diagnostic precision and expand clinical applications. In addition, increasing healthcare expenditure, expanding diagnostic imaging infrastructure in emerging economies, and supportive government screening programs for early detection of vascular disorders are accelerating market growth.
The rising prevalence of the aging population across various countries is expected to drive market growth. The older population is at higher risk of developing peripheral vascular or peripheral artery disease. According to data published by the Population Reference Bureau in January 2024, the number of individuals in America aged 65 and older is anticipated to rise by 47% from 58 million in 2022 to 82 million by 2050. The 65-and-older age group's share of the overall population is estimated to increase from 17% to 23%. Aging is considered to be the most significant risk factor for vascular and chronic diseases. The rising geriatric population is expected to increase susceptibility toward chronic conditions such as cardiovascular disorders and other lifestyle disorders, which increases the risk of developing peripheral artery disease.
The rising adoption of imaging techniques such as computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI) for diagnosing and treating conditions like peripheral artery disease (PAD) is projected to drive market growth. Several studies are currently being conducted to evaluate these imaging modalities in the context of PAD diagnosis and detection. For instance, an article published by BIBA Medical in May 2024 highlights research at the University of Twente and Rijnstate Hospital in the Netherlands investigating ultrafast contrast-enhanced ultrasound for blood flow quantification in PAD patients after endovascular treatment. Initial findings suggest that this innovative technique may offer a promising imaging alternative. The increasing number of research activities focusing on evaluating new imaging modalities for diagnosing and treating PAD is anticipated to boost market growth.
Furthermore, the demand for medical imaging has consistently increased over recent years, driven by technological advancements, an aging population, growing awareness about preventive healthcare, and the rising prevalence of chronic conditions and vascular diseases. A study published by the National Library of Medicine in October 2023 reports that nearly 40 million MRI scans are conducted annually in the U.S. In addition, European countries such as England are also widely adopting these modalities.
Global Peripheral Vascular Imaging Contrast Media Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral vascular imaging contrast media market report based on modality, product, end-use, and region: